DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin) - Acute Myeloid Leukaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Acute Myeloid Leukaemia (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include acute myeloid leukaemia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Epirubicin side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-02

Patient: 50 year old female

Reactions: Acute Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: received eight courses.

Docetaxel
    Dosage: eight courses.

Epirubicin
    Dosage: received eight courses.

Therapeutic Radiopharmaceuticals
    Dosage: received 50 gy of irradiation to conserved breast and supraclavicular fossa



Possible Epirubicin side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-13

Patient: 67 year old female

Reactions: Acute Myeloid Leukaemia, Pyrexia, Papule

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: (df), (df), (df), (df)
    Indication: Breast Cancer

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia

Docetaxel
    Dosage: (df), (df), (df), (df)
    Indication: Breast Cancer

Epirubicin
    Dosage: (df), (df), (df), (df)
    Indication: Breast Cancer

Fluorouracil
    Dosage: (df), (df), (df), (df)
    Indication: Breast Cancer

Idarubicin HCL
    Dosage: (12 mg/m2)
    Indication: Acute Myeloid Leukaemia

Mitoxantrone
    Dosage: (7 mg/m2)
    Indication: Acute Myeloid Leukaemia

Tegafur Uracil (Tegafur / Uracil)
    Dosage: (df oral)
    Administration route: Oral
    Indication: Colon Cancer

Trastuzumab (Trastuzumab)
    Dosage: (1 df 3x/week)
    Indication: Breast Cancer



Possible Epirubicin side effects in 66 year old female

Reported by a individual with unspecified qualification from Japan on 2012-04-10

Patient: 66 year old female

Reactions: Acute Myeloid Leukaemia, Pancytopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Anastrozole
    Indication: Breast Cancer
    Start date: 2008-04-01
    End date: 2008-10-01

Capecitabine
    Start date: 2007-06-01
    End date: 2007-09-01

Capecitabine
    Indication: Breast Cancer
    Start date: 2007-03-01
    End date: 2007-05-01

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2006-08-01
    End date: 2007-02-01

Cyclophosphamide
    Start date: 2007-03-01
    End date: 2007-05-01

Epirubicin
    Indication: Breast Cancer
    Start date: 2006-08-01
    End date: 2007-02-01

Fluorouracil
    Indication: Breast Cancer
    Start date: 2006-08-01
    End date: 2007-02-01

Letrozole
    Indication: Breast Cancer
    Start date: 2007-02-01

Taxotere
    Indication: Breast Cancer
    Start date: 2006-08-01

Taxotere
    Start date: 2006-11-09
    End date: 2007-01-11

Toremifene
    Start date: 2007-10-01
    End date: 2008-03-01

Toremifene
    Indication: Breast Cancer
    Start date: 2007-06-01
    End date: 2007-09-01

TS-1
    Indication: Breast Cancer Metastatic
    Start date: 2008-10-01
    End date: 2011-06-01



Possible Epirubicin side effects in 50 year old

Reported by a physician from Turkey on 2012-03-14

Patient: 50 year old

Reactions: Acute Myeloid Leukaemia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer

Docetaxel
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Therapeutic Radiopharmaceuticals
    Indication: Breast Cancer



Possible Epirubicin side effects in 45 year old

Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-03-13

Patient: 45 year old

Reactions: Acute Myeloid Leukaemia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer

Therapeutic Radiopharmaceuticals
    Indication: Breast Cancer

Other drugs received by patient: Tamoxifen Citrate



Possible Epirubicin side effects in

Reported by a physician from Turkey on 2012-03-13

Patient:

Reactions: Acute Myeloid Leukaemia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: not reported
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Dosage: not reported
    Indication: Breast Cancer

Paclitaxel
    Dosage: not reported
    Indication: Breast Cancer

Tamoxifen Citrate
    Dosage: not reported
    Indication: Breast Cancer

Therapeutic Radiopharmaceuticals
    Dosage: not reported
    Indication: Breast Cancer



Possible Epirubicin side effects in 66 year old female

Reported by a physician from Japan on 2012-01-04

Patient: 66 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Acute Myeloid Leukaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: dosage is uncertain.
    Start date: 2007-03-01
    End date: 2007-05-01

Cyclophosphamide
    Dosage: dosage is uncertain.
    Indication: Breast Cancer Metastatic
    Start date: 2006-08-11

Epirubicin
    Dosage: dosage is uncertain.
    Indication: Breast Cancer Metastatic
    Start date: 2006-08-11

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2007-03-01
    End date: 2007-05-01

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral
    Start date: 2007-06-01
    End date: 2007-09-01

Other drugs received by patient: Docetaxel (AS Comparator); Toremifene; Fluorouracil; Femara; Toremifene; Calcium Lactate; Urso 250



Possible Epirubicin side effects in

Reported by a physician from Belgium on 2011-10-04

Patient:

Reactions: Neoplasm Malignant, Acute Myeloid Leukaemia

Drug(s) suspected as cause:
Cyclophosphamide

Epirubicin

Fluorouracil

Letrozole
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-03-18

Other drugs received by patient: Lormetazepam; Calcium Carbonate; Vitamin D

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014